USP32 and ovarian carcinoma: For an instance, USP32 facilitates tumor immune escape in hepatocellular carcinoma 39, which is associated with the advancement of small cell lung cancer 40, breast cancer 41, glioblastoma 42, gastric cancer, and epithelial ovarian cancer 43.